A Digital Publication for the Practicing Medical Specialist, Industry Executive & Investor

No Carolina / New York

West Boca Medical Center Opens New Interventional Vascular Imaging Suite

West Boca Medical Center increases its services in the community by offering patients advanced vascular and interventional imaging procedures in its new imaging suite and interventional radiology lab.

The new lab will add the Siemens Artis Q system to enhance imaging and invasive services. The system features high-resolution capabilities, which enhance minimally invasive therapies for peripheral vascular disease, embolization, and diagnostic examination.

“We are excited to bring this enhanced level of interventional and vascular capabilities to our patients that can be accessed right here in their community,” said George Rizzuto, chief executive officer of West Boca Medical Center.  “Our first priority is to deliver the highest quality and safest treatments to our patients.  These services and this new lab demonstrates our commitment by continuing to bring the most current technology and resources to Palm Beach County.”

Some of the benefits of this new technology include:

  • Superior image quality that provides better visualization of small vessels, devices, and tissue.
  • Enhanced system efficiency to produce the highest image quality at the lowest possible doses.
  • Improved interventional imaging for treatment of peripheral vascular disease.
  • Ability to perform rotational imaging for 3D reconstruction and vascular road mapping.
  • Integration of other imaging modalities, including CT and ultrasound, that provides a basis for planning therapies, such as embolization of tumors.

This $4 million dollar investment will allow West Boca Medical Center to partner with sister hospital Delray Medical Center to expand its vascular services and offer patients this specialized care and technology in the community.  For more information go to www.westbocamedctr.com or call 561-488-8000.

 

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

Dr. Sachita Shah, Sr. Director, Global Health, Butterfly Network, "Butterfly is proud to continue improving maternal health equity through Phase Two of the largest-scale handheld ultrasound distribution and training ever conducted in Sub-Saharan Africa. South Africa is an emerging market that continues to have disproportionately high rates of maternal mortality and stillbirth. Patients need easier access to antenatal imaging, and clinicians need better capabilities for screening high-risk conditions that lead to disproportionately worse pregnancy outcomes in rural areas in the public sector. Together with CHAI and GUSI, we can tackle this by making ultrasound much more accessible, so high-risk conditions can be identified earlier in care, which is known to improve outcomes.”
The clinical Study will enroll up to 97 patients at up to 12 European investigational sites. Completion of the study is expected this year, and results will support CE mark and pre-market approval submissions reports Vivasure Medical.
Dr. Michael Newman, Indaptus’ Founder, Chief Scientific Officer, and lead author, commented, “The new data are consistent with our preclinical animal tumor model studies and provide evidence for our hypothesis that patented Decoy bacteria can activate a wide range of innate and adaptive human immune cells involved in fighting tumors.  This aligns with what we’ve observed in our ongoing Phase 1 clinical trial of Decoy20 – broad immune activation, as evidenced by transiently increased levels of many key cytokines and chemokines following single dose administration. These findings bolster our confidence in Decoy20's potential as a multifaceted immunotherapy.”
To further understand the impact of platforms like TikTok on nutrition trends, MyFitnessPal partnered with Dublin City University on a research and experimental study that examined diet and nutrition content on TikTok. The study analyzed over 67,000 videos using Artificial Intelligence to compare them against public health and nutrition guidelines
Leveraging the power of Apple Vision Pro to seamlessly blend digital content with the physical world Osso Health brings the operating experience to life via detailed, clinically accurate workflows of common procedures.

By using this website you agree to accept Medical Device News Magazine Privacy Policy